{"nct_id":"NCT05173987","title":"Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2022-02-03","start_date_type":"ACTUAL","primary_completion_date":"2027-05-27","primary_completion_date_type":"ESTIMATED","completion_date":"2027-05-27","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}